GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Prostate | ON | Recruiting
DEFINE & 20220698-01H
Dose Escalation For INtraprostatic LEsions (DEFINE)
Start Date: November 23, 2023

NCT #: NCT05851547

SPONSOR: Ottawa Hospital Research Institute

INFO: https://clinicaltrials.gov/study/NCT05851547

CONTACT: Scott Grimes

613-737-7700 x 70523; sgrimes@ohri.ca

Other Canadian Centres:

1. The Ottawa Hospital Cancer Centre

Renal | ON | Recruiting
HALLMARK
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients (HALLMARK)
Sunita Singh
Start Date: October 24, 2023

NCT #: NCT05938712

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/study/NCT05938712

CONTACT: Vesta Lai: vesta.lai@uhn.ca                

416-340-4800 x 8508

Other Canadian Centres:

1. Toronto General Hospital (Toronto)

Renal | NS | Not yet recruiting
QuitWIT
Novel Cooling Device for the Elimination of Warm Ischemia During Renal Transplantation (QuitWIT)
Thomas Skinner
Start Date: October 1, 2023

NCT #: NCT05166460

SPONSOR: Thomas Skinner

INFO: https://clinicaltrials.gov/study/NCT05166460

CONTACT: tomaaskinner@gmail.com

Other Canadian Centres:

1. Queen Elizabeth ll Health Sciences Centre (Halifax)

Bladder | BC, NS, ON, QC | Not yet recruiting
CANUCK-01
A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer
Dr. Paul Toren
Start Date: August 30, 2023

NCT #: NCT06018116

SPONSOR: CHU de Quebec-Universite Laval in Collaboration with Cancer Research Society

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT06018116

CONTACT: Paul.Toren@crchudequebec.ulaval.ca (CHUQ)  

Other Canadian Centres:

BCCA-Vancouver Cancer Centre (Vancouver)

QEII Health Sciences Centre (Halifax)

London Regional Cancer Program (London)

University Health Network (Toronto)

McGill University Health Centre (Montreal)

Renal | ON | Not yet recruiting
INCB 99280-205
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Incyte Corporation
Start Date: August 29, 2023

NCT #: NCT05909995

SPONSOR: Incyte Corporation

INFO: https://clinicaltrials.gov/study/NCT05909995

CONTACT: 1-855-463-3464

medinfo@incyte.com

Other Canadian Centres:

Princess Margaret Cancer Centre (Toronto)

Renal | ON | Recruiting
1000080780
iParent2Parent Peer Support Program for Parents of Pediatric Kidney Transplant Recipients
Samantha J. Anthony
Start Date: August 1, 2023

NCT #: NCT05968833

SPONSOR: The Hospital for Sick Children

INFO: https://clinicaltrials.gov/study/NCT05968833

CONTACT: 416-813-7654 ext 303126                     

samantha.anthony@sickkids.ca

Other Canadian Centres:

1. The Hospital for Sick Children (Toronto)

Renal | ON | Recruiting
PRT01
Prebiotic Therapy to Improve Outcomes of Renal Transplant
Alp Sener
Start Date: February 22, 2023

NCT #: NCT04428190

SPONSOR: Lawson Health Research Institute

INFO: https://clinicaltrials.gov/study/NCT04428190

CONTACT: Cadence Baker: cadence.baker@lhsc.on.ca        

519-685-8500 x 34755

Other Canadian Centres:

1. London Health Sciences Centre (London)

Renal | ON | Recruiting
AQuOS-ll
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT (AQuOS-II)
Dr. William Chu
Start Date: January 10, 2023

NCT #: NCT05023265

SPONSOR: Sunnybrook Health Sciences Centre

INFO: https://clinicaltrials.gov/study/NCT05023265?term=NCT05023265&rank=1

CONTACT:  

1. Dr. William Chu (Sunnybrook) 
Contact Coordinator: Murtuza Saifuddin: murtuza.saifuddin@sunnybrook.ca
2. Dr. Anand Swaminath (Hamilton)
Contact Coordinator: Carmela Oliverio: coliveri@HHSC.CA
3. Dr. Howard Pai (Victoria)
Contact Coordinator:  Emily White: emil.white@bccancer.bc.ca
4. Dr. Darin GoPaul (Kitchener)
Contact Coordinator: Atif Siddiqui: Atif.Siddiqui@grhosp.on.ca
5. Dr. Lucas Mendez (London)
Contact Coordinator:  Kes.Sebborn@lhsc.on.ca
6. Dr. Mark Richard Niglas (Oshawa)
Contact Coordinator: Mary Tannourji: mtannourji@lh.ca 

OTHER CANADIAN CENTRES:

1. Hamilton Health Sciences/Juravinski Cancer Centre
2. BC Cancer Agency (Victoria)
3. Health Sciences North (Sudbury)
4. Grant River (Kitchener)
5. London Health Sciences Centre
6. Lakeridge Health, RS McLaughlin Durham Reg Cancer Centre (Oshawa)

Prostate | ON | Recruiting
MIDAS-Prostate
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
Dr. Srinivas Raman
Start Date: November 1, 2022

NCT #: NCT05328505

SPONSOR: University Health Network, Toronto

INFO: https://www.clinicaltrials.gov/ct2/show/NCT05328505

CONTACT: 416-946-2320 

Renal | ON | Recruiting
CKFA115A12101
A Study of Safety and Efficacy of KFA115 Alone and KFA115 in Combination With Tislelizumab in Patients With Select Advanced Cancers
Novartis Pharmaceuticals
Start Date: October 26, 2022

NCT #: NCT05544929

SPONSOR: Novartis Pharmaceuticals

INFO: https://clinicaltrials.gov/study/NCT05544929

CONTACT: 1-888-669-6682                                        

novartis.email@novartis.com

Other Canadian Centres:

Princess Margaret Cancer Centre (Toronto)

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy